Introduction: prostate enlargement is histologic diagnosis that refers to the proliferation of glandular epithelial tissue, smooth muscle, and connective tissue within the prostatic transition zone. Objectives: The study objectives are to measure prevalence of prostate cancer in patients with prostate enlargement. Methods: The study was a descriptive cross-sectional hospital. Base study carried out on fifty patients. Results: 100% of study population did digital rectal examination, 90% of study elements did SPA test, 38% of them were positive, 48% negative. 82% of study population did U/S examination, and 84% did biopsy. 94% of population said that; they know about the disease. Conclusion: The study concluded that prostate cancer is threat for prostate enlargement patients.
| Published in | Journal of Cancer Treatment and Research (Volume 12, Issue 1) |
| DOI | 10.11648/jctr.20241201.11 |
| Page(s) | 1-4 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Prostate, Prostate Enlargement, Cancer Sudan
| [1] | https://emedicine.medscape.com/article/1923122-overview Updated: Sep 13, 2017 Author: Nicolas A Muruve, MD, FACS, FRCSC; Chief Editor: Thomas R Gest, PhD "Prostate cancer - PSA testing - NHS Choices". NHS Choices. 3 January 2015. |
| [2] | Data sources Electronic search of Cochrane Central Register of Controlled Trials, Web of Science, Embase, Scopus, OpenGrey, LILACS, and Medline, and search of scientific meeting abstracts and trial registers to April 2018. "Human PubMed Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764233/ |
| [3] | https: Kiyoshima K, Yokomizo A, Yoshida T, Tomita K, Yonemasu H, Nakamura M, et al. Anatomical features of periprostatic tissue and its surroundings: a histological analysis of 79radical retropubic prostatectomy specimens. Jpn J Clin Oncol. 2004 Aug. 34. |
| [4] | "Prostate Cancer Treatment (PDQ) – Health Professional Version". National Cancer Institute. 2014-04-11. Archived from the original on 5 July 2014. Retrieved 1 July 2014. |
| [5] | "Prostate Cancer Treatment (PDQ) – Patient Version". National Cancer Institute. 2014-04-08. Archived from the original on 5 July 2014. Retrieved 1 July 2014. |
| [6] | "Chapter 5.11". World Cancer Report. World Health Organization. 2014. ISBN 978-9283204299. |
| [7] | "SEER Stat Fact Sheets: Prostate Cancer". NCI. Archived from the original on 6 July 2014. Retrieved 18 June 2014. |
| [8] | Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (November 2018). "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries". Ca: A Cancer Journal for Clinicians. 68(6): 394–424. doi: 10.3322/caac.21492. PMID 30207593. |
| [9] | "Prostate Cancer". National Cancer Institute. January 1980. Archived from the original on 12 October 2014. Retrieved 12 October 2014. |
| [10] | Ruddon, Raymond W. (2007). Cancer biology (4th ed.). Oxford: Oxford University Press. p. 223. ISBN 978-0195175431. Archived from the original on 2015-09-15. |
| [11] | Caini S, Gandini S, Dudas M, Bremer V, Severi E, Gherasim A (August 2014). "Sexually transmitted infections and prostate cancer risk: a systematic review and meta-analysis". Cancer Epidemiology. 38(4): 329–38. doi: 10.1016/j.canep.2014.06.002.PMID 24986642. |
| [12] | Lee MV, Katabathina VS, Bowerson ML, Mityul MI, Shetty AS, Elsayes KM, et al. (2016). "BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management". Radiographics. 37(4): 1005–1023. doi: 10.1148/rg.2017160144. PMID 28548905. |
| [13] | "Prostate Cancer Treatment". National Cancer Institute. 6 February 2018. Retrieved 1 March 2018. Controversy exists regarding the value of screening... reported no clear evidence that screening for prostate cancer decreases the risk of death from prostate cancer. |
| [14] | Catalona WJ (March 2018). "Prostate Cancer Screening". The Medical Clinics of North America. 102(2): 199–214. doi: 10.1016/j.mcna.2017.11.001. PMC 5935113. PMID 29406053. |
| [15] | "PSA testing". nhs.uk. 3 January 2015. Retrieved 5 March 2018. 19."Final Recommendation Statement: Prostate Cancer: Screening –US Preventive Services Task Force". www.uspreventiveservicestaskforce.org. USPSTF. Retrieved 30 August 2018. |
| [16] | Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, et al. (May 2018). "Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement". JAMA. 319(18): 1901–1913. doi: 10.1001/jama.2018.3710. PMID 29801017. |
| [17] | Cabarkapa S, Perera M, McGrath S, Lawrentschuk N (December 2016). "Prostate cancer screening with prostate-specific antigen: A guide to the guidelines". Prostate International. 4(4): 125–129. doi: 10.1016/j.prnil.2016.09.002. PMC 5153437. PMID 27995110. |
| [18] | Stratton J, Godwin M (June 2011). "The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis". Family Practice. 28(3): 243–52. doi: 10.1093/fampra/cmq115. PMID 21273283. |
| [19] | "Chapter 1.1". World Cancer Report. World Health Organization. 2014. ISBN 978-9283204299. |
| [20] | Baade PD, Youlden DR, Krnjacki LJ (February 2009). "International epidemiology of prostate cancer: geographical distribution and secular trends". Molecular Nutrition & Food Research. 53(2): 171–84. doi: 10.1002/mnfr.200700511. PMID 19101947. |
| [21] | Miller DC, Hafez KS, Stewart A, Montie JE, Wei JT (September 2003). "Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base" (PDF). Cancer. 98(6): 1169–78. doi: 10.1002/cncr.11635. hdl: 2027.42/34379. PMID 12973840. |
| [22] | van der Cruijsen-Koeter IW, Vis AN, Roobol MJ, Wildhagen MF, de Koning HJ, van der Kwast TH, Schröder FH (July 2005). "Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam". The Journal of Urology. 174(1): 121–5. doi: 10.1097/01.ju.0000162061.40533.0f. PMID 15947595. |
APA Style
Ahmed, A. S. A. A. A., Amin, M. H. J. (2024). Prostate Cancer in Patients with Enlarged Prostate, Ibn Sina Hospital, 2020. Journal of Cancer Treatment and Research, 12(1), 1-4. https://doi.org/10.11648/jctr.20241201.11
ACS Style
Ahmed, A. S. A. A. A.; Amin, M. H. J. Prostate Cancer in Patients with Enlarged Prostate, Ibn Sina Hospital, 2020. J. Cancer Treat. Res. 2024, 12(1), 1-4. doi: 10.11648/jctr.20241201.11
AMA Style
Ahmed ASAAA, Amin MHJ. Prostate Cancer in Patients with Enlarged Prostate, Ibn Sina Hospital, 2020. J Cancer Treat Res. 2024;12(1):1-4. doi: 10.11648/jctr.20241201.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/jctr.20241201.11,
author = {Arwa Salah Aldin Abd Alraheem Ahmed and Mohammed Hammad Jaber Amin},
title = {Prostate Cancer in Patients with Enlarged Prostate, Ibn Sina Hospital, 2020},
journal = {Journal of Cancer Treatment and Research},
volume = {12},
number = {1},
pages = {1-4},
doi = {10.11648/jctr.20241201.11},
url = {https://doi.org/10.11648/jctr.20241201.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.jctr.20241201.11},
abstract = {Introduction: prostate enlargement is histologic diagnosis that refers to the proliferation of glandular epithelial tissue, smooth muscle, and connective tissue within the prostatic transition zone. Objectives: The study objectives are to measure prevalence of prostate cancer in patients with prostate enlargement. Methods: The study was a descriptive cross-sectional hospital. Base study carried out on fifty patients. Results: 100% of study population did digital rectal examination, 90% of study elements did SPA test, 38% of them were positive, 48% negative. 82% of study population did U/S examination, and 84% did biopsy. 94% of population said that; they know about the disease. Conclusion: The study concluded that prostate cancer is threat for prostate enlargement patients.
},
year = {2024}
}
TY - JOUR T1 - Prostate Cancer in Patients with Enlarged Prostate, Ibn Sina Hospital, 2020 AU - Arwa Salah Aldin Abd Alraheem Ahmed AU - Mohammed Hammad Jaber Amin Y1 - 2024/02/01 PY - 2024 N1 - https://doi.org/10.11648/jctr.20241201.11 DO - 10.11648/jctr.20241201.11 T2 - Journal of Cancer Treatment and Research JF - Journal of Cancer Treatment and Research JO - Journal of Cancer Treatment and Research SP - 1 EP - 4 PB - Science Publishing Group SN - 2376-7790 UR - https://doi.org/10.11648/jctr.20241201.11 AB - Introduction: prostate enlargement is histologic diagnosis that refers to the proliferation of glandular epithelial tissue, smooth muscle, and connective tissue within the prostatic transition zone. Objectives: The study objectives are to measure prevalence of prostate cancer in patients with prostate enlargement. Methods: The study was a descriptive cross-sectional hospital. Base study carried out on fifty patients. Results: 100% of study population did digital rectal examination, 90% of study elements did SPA test, 38% of them were positive, 48% negative. 82% of study population did U/S examination, and 84% did biopsy. 94% of population said that; they know about the disease. Conclusion: The study concluded that prostate cancer is threat for prostate enlargement patients. VL - 12 IS - 1 ER -
Faculty of Medicine, Alzaiem Alazhari University, Khartoum, Sudan
